Ostrowska K, Horosz G, Kruk K, Sieron B, Lesniak A, Czartoryska Z
Int J Mol Sci. 2025; 26(5).
PMID: 40076572
PMC: 11900313.
DOI: 10.3390/ijms26051946.
Dijkstra M, Schueffl H, Federa A, Kast C, Unterlercher A, Keppler B
ACS Omega. 2025; 10(5):5047-5063.
PMID: 39959040
PMC: 11822723.
DOI: 10.1021/acsomega.4c10825.
Soliman M, Elwahy A, Sayed A, Ibrahim M, Dawoud M, Ali S
Naunyn Schmiedebergs Arch Pharmacol. 2025; .
PMID: 39831977
DOI: 10.1007/s00210-024-03780-7.
Boley A, Genova J, Nicewicz D
J Am Chem Soc. 2024; 146(45):31274-31280.
PMID: 39484714
PMC: 11755930.
DOI: 10.1021/jacs.4c12028.
Soltani Rad M, Behrouz S, Yazdi P, Hashemi S, Behrouz M
RSC Adv. 2024; 14(39):28669-28683.
PMID: 39257660
PMC: 11384933.
DOI: 10.1039/d4ra06244b.
Synthesis of novel piperazine-based bis(thiazole)(1,3,4-thiadiazole) hybrids as anti-cancer agents through caspase-dependent apoptosis.
Mohamed D, Kheder N, Sharaky M, Nafie M, Dawood K, Abbas A
RSC Adv. 2024; 14(34):24992-25006.
PMID: 39131497
PMC: 11310838.
DOI: 10.1039/d4ra05091f.
A new crystalline daidzein-piperazine salt with enhanced solubility, permeability, and bioavailability.
Meng J, Qiu C, Lu C, He X, Zhao X
Front Pharmacol. 2024; 15:1385637.
PMID: 39104399
PMC: 11298695.
DOI: 10.3389/fphar.2024.1385637.
Pharmaceutical Studies on Piperazine-based Compounds Targeting Serotonin Receptors and Serotonin Reuptake Transporters.
Yamali C, Nenni M, Sakarya M, Kaplan H
Mini Rev Med Chem. 2024; 25(1):58-75.
PMID: 38910275
DOI: 10.2174/0113895575319878240612070850.
A survey of isatin hybrids and their biological properties.
Shu V, Eni D, Ntie-Kang F
Mol Divers. 2024; 29(2):1737-1760.
PMID: 38833124
DOI: 10.1007/s11030-024-10883-z.
Synthetic Protocols, Structural Activity Relationship, and Biological Activity of Piperazine and its Derivatives.
Faizan M, Kumar R, Mazumder A, Salahuddin , Kukreti N, Kumar A
Med Chem. 2024; 20(8):753-780.
PMID: 38685782
DOI: 10.2174/0115734064304396240415110015.
Design, synthesis and biological evaluation of rhein-piperazine-furanone hybrids as potential anticancer agents.
He Y, Zhang S, Wei M
RSC Med Chem. 2024; 15(3):848-855.
PMID: 38516604
PMC: 10953484.
DOI: 10.1039/d3md00619k.
Utility of 2-Chloro--arylacetamide and 1,1'-(Piperazine-1,4-diyl)bis(2-chloroethanone) as Versatile Precursors for Novel Mono- and Bis[thienopyridines].
Salem M, Abdullah A, Zaki M, Abdelhamid I, Elwahy A
ACS Omega. 2024; 9(9):10146-10159.
PMID: 38463260
PMC: 10918660.
DOI: 10.1021/acsomega.3c06653.
Novel piperazine-1,2,3-triazole leads for the potential treatment of pancreatic cancer.
Sun J, Baker J, Russell C, Pham H, Goldsmith C, Cossar P
RSC Med Chem. 2023; 14(11):2246-2267.
PMID: 37974967
PMC: 10650957.
DOI: 10.1039/d2md00289b.
Alicyclic-Amine-Derived Imine-BF Complexes: Easy-to-Make Building Blocks for the Synthesis of Valuable α-Functionalized Azacycles.
Dutta S, Kim J, Bhatt K, Rickertsen D, Abboud K, Ghiviriga I
Angew Chem Int Ed Engl. 2023; 63(1):e202313247.
PMID: 37909921
PMC: 10835740.
DOI: 10.1002/anie.202313247.
Ultrafast C-C and C-N bond formation reactions in water microdroplets facilitated by the spontaneous generation of carbocations.
Wang T, Li Z, Gao H, Hu J, Chen H, Xu J
Chem Sci. 2023; 14(41):11515-11520.
PMID: 37886101
PMC: 10599473.
DOI: 10.1039/d3sc03870j.
Design, synthesis, anticancer and assessment of 8-piperazinyl caffeinyl-triazolylmethyl hybrid conjugates.
Soltani Rad M, Behrouz S, Shahbazkhani K, Behrouz M, Zarenezhad E, Ghanbariasad A
RSC Adv. 2023; 13(35):24656-24673.
PMID: 37601597
PMC: 10436028.
DOI: 10.1039/d3ra04817a.
Building Up a Piperazine Ring from a Primary Amino Group via Catalytic Reductive Cyclization of Dioximes.
Pospelov E, Sukhorukov A
Int J Mol Sci. 2023; 24(14).
PMID: 37511552
PMC: 10380651.
DOI: 10.3390/ijms241411794.
Design and synthesis of pyrrolo[2,3-d]pyrimidine linked hybrids as α-amylase inhibitors: molecular docking, MD simulation, ADMET and antidiabetic screening.
Zala A, Tiwari R, Naik H, Ahmad I, Patel H, Jauhari S
Mol Divers. 2023; 28(3):1681-1695.
PMID: 37344700
DOI: 10.1007/s11030-023-10683-x.
Mechanistic insight and structure activity relationship of isatin-based derivatives in development of anti-breast cancer agents.
Singh A, Singh K, Sharma A, Sharma S, Batra K, Joshi K
Mol Cell Biochem. 2023; 479(5):1165-1198.
PMID: 37329491
DOI: 10.1007/s11010-023-04786-0.
Iridium-Catalyzed Regio- and Diastereoselective Synthesis of C-Substituted Piperazines.
Tarifa L, Pilar Del Rio M, Asensio L, Lopez J, Ciriano M, Geer A
ACS Catal. 2023; 13(5):3148-3152.
PMID: 36910865
PMC: 9990149.
DOI: 10.1021/acscatal.2c05895.
